South Tulsa Pathology Laboratory, Inc. - Page 22




                                       - 22 -                                         
          limited to:  (1) The importance of achieving the purpose to the             
          success of the business; (2) the extent to which the transaction            
          is prompted by a person not having a proprietary interest in                
          either corporation, or by other outside factors beyond the                  
          control of the distributing corporation; and (3) the immediacy of           
          the conditions prompting the transaction.  Sec. 1.355-2(d)(3)(i)            
          and (ii), Income Tax Regs.                                                  
               Petitioner identifies three purported corporate business               
          purposes for the disputed distribution:  (1) Increased                      
          competition caused by a changing economic environment that                  
          favored the larger, national laboratories; (2) Oklahoma State law           
          restricting the ownership of petitioner to licensed physicians or           
          physician-owned entities licensed to practice medicine within               
          Oklahoma; and (3) NHL’s requirement that each of petitioner’s               
          physician-shareholders sign binding and enforceable covenants not           
          to compete in the clinical laboratory business.  Respondent                 
          contends there was no valid corporate business purpose for the              
          distribution.  We consider each of the purported corporate                  
          business purposes below.                                                    
                                   i.   Increased Competition                         
               The first purported corporate business purpose asserted by             
          petitioner is that the changing economic environment in the                 
          clinical laboratory market in 1993 favored the large, national              
          laboratories over the smaller clinical laboratories, such as                






Page:  Previous  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  Next

Last modified: May 25, 2011